These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 26042389)
21. Antibiotic resistance: from Darwin to Lederberg to Keynes. Amábile-Cuevas CF Microb Drug Resist; 2013 Apr; 19(2):73-87. PubMed ID: 23046150 [TBL] [Abstract][Full Text] [Related]
22. Compatibility of Evolutionary Responses to Constituent Antibiotics Drive Resistance Evolution to Drug Pairs. Jahn LJ; Simon D; Jensen M; Bradshaw C; Ellabaan MMH; Sommer MOA Mol Biol Evol; 2021 May; 38(5):2057-2069. PubMed ID: 33480997 [TBL] [Abstract][Full Text] [Related]
23. Use of genomics to select antibacterial targets. Pucci MJ Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986 [TBL] [Abstract][Full Text] [Related]
24. Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance. Pokrovskaya V; Baasov T Expert Opin Drug Discov; 2010 Sep; 5(9):883-902. PubMed ID: 22823262 [TBL] [Abstract][Full Text] [Related]
25. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. Cai Y; Chai D; Wang R; Liang B; Bai N J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575 [TBL] [Abstract][Full Text] [Related]
26. Antibiotic resistance in bacteria and its future for novel antibiotic development. Yoneyama H; Katsumata R Biosci Biotechnol Biochem; 2006 May; 70(5):1060-75. PubMed ID: 16717405 [TBL] [Abstract][Full Text] [Related]
27. RNAi for silencing drug resistance in microbes toward development of nanoantibiotics. Edson JA; Kwon YJ J Control Release; 2014 Sep; 189():150-7. PubMed ID: 24995951 [TBL] [Abstract][Full Text] [Related]
28. [Adverse effects of interactions of antibiotics with other drugs]. Zebrowska-Łupina I; Szymczyk G; Wróbel A Pol Merkur Lekarski; 2000 Sep; 9(51):623-6. PubMed ID: 11126991 [TBL] [Abstract][Full Text] [Related]
33. [Interactions between antibiotics (author's transl)]. Ata H Mikrobiyol Bul; 1980 Jan; 14(1):53-64. PubMed ID: 7453586 [TBL] [Abstract][Full Text] [Related]
34. Recent approaches in design of peptidomimetics for antimicrobial drug discovery research. Lohan S; Bisht GS Mini Rev Med Chem; 2013 Jun; 13(7):1073-88. PubMed ID: 23621691 [TBL] [Abstract][Full Text] [Related]
35. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates. Deveci A; Coban AY; Acicbe O; Tanyel E; Yaman G; Durupinar B J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043 [TBL] [Abstract][Full Text] [Related]
36. The antibiotic resistome: the nexus of chemical and genetic diversity. Wright GD Nat Rev Microbiol; 2007 Mar; 5(3):175-86. PubMed ID: 17277795 [TBL] [Abstract][Full Text] [Related]
37. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]